The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity.
Javier AmpueroRocio AllerRocío Gallego-DuránJesus M BanalesJavier CrespoCarmelo García-MonzónMaría Jesús ParejaEduardo Vilar-GómezJuan CaballeríaDesamparados Escudero-GarcíaJudith Gomez-CamareroJosé Luis CallejaMercedes LatorreAgustín AlbillosJavier SalmeronPatricia AspichuetaOreste Lo IaconoRubén FrancesSalvador BenllochConrado Fernández-RodríguezJavier García-SamaniegoPamela EstévezRaúl J AndradeJuan TurnesManuel Romeronull nullPublished in: Alimentary pharmacology & therapeutics (2018)
Metabolic unhealthy status showed a greater impact on NASH, significant fibrosis, kidney dysfunction, and atherogenic profile than obesity. However, metabolically healthy obesity was not a full healthy condition. We should focus our messages especially on patients with adverse metabolic conditions.